Cardiogenic Shock and the Role of Critical Care Cardiology: Evidence, Models of Care, and Future Directions

Alexandra N Schwann1, Alexander Ambrosini1, Tariq N Ali1

  • 1Section of Cardiovascular Medicine, Department of Internal Medicine, Yale School of Medicine, New Haven, Connecticut.

Insights

Critical care cardiology (CCC) addresses the complex needs of modern cardiac intensive care units (CICUs). This subspecialty enhances care for cardiogenic shock (CS) patients through integrated expertise and coordinated teams.

Area of Science:

  • Cardiology
  • Intensive Care Medicine
  • Critical Care Cardiology

Background:

  • Modern cardiac intensive care units (CICUs) manage sicker patients with complex noncardiac conditions.
  • Cardiogenic shock (CS) remains a significant challenge with poor outcomes despite advances.
  • Traditional care models struggle with the evolving CICU patient population.

Purpose of the Study:

  • To review the development and impact of critical care cardiology (CCC).
  • To discuss intensive care unit staffing models relevant to CCC.
  • To summarize evidence supporting cardiogenic shock (CS) teams.

Main Methods:

  • Literature review on critical care cardiology.
  • Analysis of intensive care unit staffing models.
  • Synthesis of evidence on cardiogenic shock team effectiveness.

Main Results:

  • Critical care cardiology combines cardiovascular and critical care expertise.
  • Dual expertise enables better management of complex CICU patients, including those with CS.
  • Multidisciplinary CS teams improve coordination and decision-making.

Conclusions:

  • Critical care cardiology is vital for addressing modern CICU challenges.
  • Investment in CCC training, research, and infrastructure is essential.
  • Optimized staffing and CS teams are key to improving patient outcomes.

Related Concept Videos

Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
Cardiopulmonary Resuscitation IV: Pharmacological Management01:25

Cardiopulmonary Resuscitation IV: Pharmacological Management

Pharmacologic intervention is crucial in treating cardiac arrest patients during ACLS or Advanced Cardiovascular Life Support. The ACLS algorithms guide the administration of specific drugs based on the patient's cardiac arrest rhythm, which includes pulseless ventricular tachycardia (VT), ventricular fibrillation (VF), asystole, and pulseless electrical activity (PEA).EpinephrineIndication: Epinephrine is the first-line drug for all cardiac arrest rhythms.Mechanism of Action: Epinephrine...
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Blood Pressure Imbalances and Circulatory Shock01:24

Blood Pressure Imbalances and Circulatory Shock

Disorders affecting blood volume, vascular tone, or vascular function can disrupt vascular homeostasis, including conditions like hypertension, hemorrhage, and shock.
Blood Pressure: Hypertension and Hypotension
Normal blood pressure is 120/80 mm Hg. Elevated blood pressure is 120-129/under 80 mm Hg. Hypertension, warranting treatment at 130/80 mm Hg, is often asymptomatic and can lead to severe cardiovascular events, aneurysms, peripheral arterial disease, chronic renal disease, or cardiac...